Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > Asia > Malaysia
Category: All Categories > Life Sciences > Healthcare > Country Overviews
(5 reports matching your criteria)
 
Malaysia Healthcare Industry 1H13
5/31/2013 | published by: Emerging Markets Direct Reports
... growth opportunities and market trends, industry SWOT, healthcare incentives and healthcare reforms, plus the profile, comparative matrix and SWOT analysis of the industry's leading players: KPJ Healthcare Berhad (KPJ), TMC Life Sciences Berhad (TMCL) and ...  |  read more...
$465.00
Malaysia Pharmaceuticals and Healthcare Report Q2 2013
3/20/2013 | published by: Business Monitor International
... taken to separate the roles of prescribing anddispensation (currently both tasks are undertaken by doctors), which will give patients greater choice andwill help boost the generic drug sector. Malaysia is also pioneering in the halal ...  |  read more...
$1,175.00
Malaysia Pharmaceuticals and Healthcare Report Q4 2012
9/19/2012 | published by: Business Monitor International
... isexperiencing increased investment in public healthcare as existing facilities are modernised. Genericdrugs are one key growth area, particularly as drug patents expire, and the government’s intention tocreate a new regulatory body and implement the Medicine ...  |  read more...
$1,175.00
Malaysia Pharmaceuticals and Healthcare Report Q3 2012
7/10/2012 | published by: Business Monitor International
... 2016, the Malaysian drug market, valued at around MYR5.55bn (US$1.81bn) in 2011, is expected to post a compound annual growth rate (CAGR) of 9.4% in local currency terms, driven primarily by the expansion and modernisation ...  |  read more...
$1,175.00
Malaysia Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
... of individual funding for medicines, given the high out-of-pocketcontribution to healthcare. Nevertheless, volume demand will continue to grow on the back of demographic andepidemiological changes, supported by the expansion of modernisation of healthcare provision in ...  |  read more...
$1,175.00